GLUE
Monte Rosa Therapeutics, Inc. Common Stock
$19.72
1.65%
+0.32
Notify me if price changes either direction
Buy GLUE stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.7B
Enterprise value
1.0B
Trailing PE
49.21875
Forward PE
-10.86094
PEG Ratio
-0.27504595588235
Enterprise to EBITDA
-7.417
Enterprise to revenue
24.164
Price to book MRQ
3.1841679
Price to sales TTM
38.765373
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
43.0M
EBITDA
-139940992
Diluted EPS TTM
-1.48
Total Cash (MRQ)
666.2M
Current ratio (MRQ)
9.538
Operating Cash Flow (TTM)
-14675000
GLUE trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
